Skip to main content

Table 2 Do you have a locally agreed protocol for the detection of the following problems following treatment for DTC?

From: Treatment related morbidity in differentiated thyroid cancer–a survey of clinicians

Complication (number of responders)

NA/Not involved

Don’t know

No agreed arrangements

Informal arrangements

Formal protocol

Temporary hypocalcaemia (118)

1 (0.8%)

1 (0.8)

7(5.9%)

32 (21.7%)

77 (65.3%)

Long term hypocalcaemia (117)

2 (1.7%)

0 (0.0%)

13 (11.1%)

51 (43.6%)

51 (43.6%)

Significant voice change (118)

2 (1.7%)

2 (1.7%)

20 (16.9%)

61 (51.7%)

33 (28.0%)

Symptoms/poor quality of life from TSH suppression (118)

14 (11.9%)

5 (4.2%)

43 (36.4%)

53 (44.9%)

3 (2.5%)

Bone/CVS complications from TSH suppression (118)

17 (14.4%)

8 (6.8%)

47 (39.8%)

42 (35.6%)

4(3.4%)

  1. NA, not applicable; CVS, cardiovascular; TSH, thyroid stimulating hormone.